Delivery Order SPE2D021DA002-SPE2D325F467Y
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, for the supply of Isentress 400 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,093.62. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499.99...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order on July 30, 2025, for 60 tablets of Isentress 400 mg with a ceiling value of $6,280.86. This firm fixed-price delivery order, which is due for completion by July 31, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,429.30 for 60 tablets of Isentress 400 mg on June 3, 2025, with an ultimate completion date of June 6, 2025. The contract carries no set-aside designation and is funded through the Medical Supply Chain, a Defense agency component. This delivery order represents a single pharmaceutical transaction under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18.8K on August 25, 2025, for the supply of Isentress 400 mg tablets (60-count units). The award was issued by the Defense Logistics Agency's Medical Supply Chain division with an ultimate completion date of August 26, 2025. This delivery order carries no set-aside designation and represents a single purchase order under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,280.86 on August 18, 2025, for the supply of Isentress 400 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The award represents a continuation of DMS...
- The U.S. Defense Logistics Agency, operating through the Medical Supply Chain division, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for $2,093.62 on September 29, 2025. The order covers 60 tablets of Isentress 400 mg, an antiretroviral medication used in HIV treatment, with delivery to Park Ridge, Illinois and a completion deadline of September 30, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's status as a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,093.62 for the supply of Isentress 400 mg tablets (60-count) to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a tactical procurement of antiretroviral medication to support Department of Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 25, 2025, to supply Isentress 400 mg tablets (60-count units) to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, valued at $20,936.20, represents a single-award contract with an ultimate completion date of August 26, 2025. The award was made without a set-aside designation, enabling DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
- On August 28, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $2,093.62 to DMS Pharmaceutical Group Inc. for the supply of Isentress 400 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of August 29, 2025. This delivery order was issued without a...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F467YDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,936.20 for 60 tablets of Isentress 400 mg on September 29, 2025. The contract, which has no set-aside designation, is set to conclude on September 30, 2025, and will be performed at the vendor's Park Ridge, Illinois location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion agreement through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense medical supply requirements. Isentress is an antiretroviral medication used in HIV treatment regimens. As a crucial supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established IDC to fulfill periodic delivery orders for prescription medications and medical consumables distributed to military health facilities worldwide. The company's contract portfolio demonstrates consistent success in competing for pharmaceutical procurement opportunities with the Defense Logistics Agency, supporting the Medical Supply Chain function of the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 9/29/25 |